Pharmafile Logo
Pharmafocus logo
Advanced Search

Shire launches Vpriv to capitalise on Genzyme woes

March 2, 2010
Sales and Marketing Cerezyme, Gaucher's, Shire

Shire has gained US approval to launch Vpriv, its new treatment for Gaucher’s disease, which it hopes will steal market …

News
ResearchPartnershipDavidWhite

David White joins The Research Partnership

March 2, 2010
Sales and Marketing The Research Partnership, appointment, sales and marketing

The Research Partnership has appointed David White director of syndicated services. Based in London, David will oversee the development and …

Appointment

Kinex Pharmaceuticals appoints Rudolf Kwan

March 2, 2010
Research and Development Kinex Pharmaceuticals, appointment, research and development

Dr Rudolf Kwan has joined Buffalo, US-based  Kinex Pharmaceuticals as chief medical officer. He will be responsible for the design …

Appointment

Clinical research news in brief

March 2, 2010
Research and Development Community Research, Evotec, FDA, INC Research, Kendle, Parexel

A round-up of recent developments in the clinical research arena includes proposals from the FDA on reporting falsified trials, Kendle’s …

News

Quotient Bioresearch Presents Comprehensive Drug Development Capabilities via New Company Website

March 1, 2010
Research and Development

Quotient Bioresearch partners its clients with a unique offering of leading-edge technologies and services for all stages of early drug …

News
Press release
Merck KGaA

Merck KGaA invests in bioresearch and bioproduction

March 1, 2010
Manufacturing and Production, Research and Development Biochemistry, Merck KGaA, Merck Serono, Millipore, laboratory services

Merck KGaA has bought US life sciences company Millipore Corporation in a $7.2 billion deal to expand its chemicals business. …

News

Single orphan document will simplify process for industry

March 1, 2010
Research and Development EMA, FDA, Orphan

The FDA and European Medicines Agency are to simplify the regulatory process for orphan medicines by agreeing to accept a …

News
Brazil

Emerging Markets: finding your way in a Brave New World

March 1, 2010
Sales and Marketing Brazil, China, India, Russia, em, emerging markets, sales, sales force effectiveness

Ask almost any pharmaceutical marketer where the future growth lies for the industry, and the answer will be almost certainly …

Feature

Kerrita McClaughlyn joins Hill & Knowlton

March 1, 2010
Medical Communications Hill & Knowlton, appointment, medical communications

Hill & Knowlton International Belgium has appointed Kerrita McClaughlyn as an account manager in its healthcare communications team. In her …

Appointment
ICON headquarters

ICON sees revenues rise in 2009

March 1, 2010
Research and Development CRO, ICON

Contract research organisation ICON saw its revenues increase 3% to $888 million last year and says it is “positive, though …

News

Pfizer’s Kristin Peck gains business development role

March 1, 2010
Sales and Marketing Pfizer, appointment, sales and marketing

Kristin Peck has been appointed senior vice president, worldwide business development, strategy and innovation at Pfizer. She succeeds William Ringo …

Appointment

Alimta recommended as maintenance therapy

March 1, 2010
Sales and Marketing Alimta, Cancer, NSCLC, lilly

 NICE has recommended Alimta as a maintenance treatment for people with locally advanced or metastatic non-small cell lung cancer. Patients …

News

Sanofi’s BSI-201 tipped for success in triple negative breast cancer

February 28, 2010
Sales and Marketing Cancer, PARP, Sanofi, breast cancer

 Sanofi-Aventis’s BSI-201 will garner sales of $1.7 billion in the triple negative breast cancer drug market in 2018, according to …

News

Failings at Lilly Humalog plant catch FDA’s eye

February 26, 2010
Manufacturing and Production Humalog, lilly

Eli Lilly has been sent a warning letter about a production facility in Puerto Rico, which says the company failed …

News

Zeltia continue strong growth

February 26, 2010
Sales and Marketing 2009 financials, PharmaMar, Yondelis, Zeltia

Consolidated revenues at Spanish biopharmaceutical company Zeltia increased by 17% to 123.4 million euros enabling it to halve operating losses. …

News

Bayer pharma sales overcome European decline

February 26, 2010
Sales and Marketing 2009 financials, Bayer, Xarelto

Bayer’s group sales dropped 5% to 31 billion euros in a “difficult year” for the company that saw a drop …

News

Talking Point: The future for pharmaceutical delivery

February 26, 2010
Manufacturing and Production Polar Speed, Talking Point, logistics, supply chain, talking logistics

Will the future for pharmaceutical delivery need to become more exacting and regulated? An ever greater awareness of the need …

Feature

Quotient Clinical receives MHRA Supplementary Accreditation

February 26, 2010
Research and Development Quotient

 This is one of the highest levels of accreditation in Europe and confirms that Quotient Clinical is qualified to perform …

Feature
Case study
Press release

Government ups the ante in dementia research

February 26, 2010
Research and Development Alzheimer's, dementia

The government has attempted to ‘up the ante’ in dementia research by convening a ministerial group comprising charities, scientists, research …

News

Nick Workman joins A La Carte

February 26, 2010
Business Services A La Carte, appointment, business services

Life sciences recruitment search consultancy A La Carte has appointed Nick Workman as international director. In his new role he …

Appointment
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026